RPS13P5

Across TCGA pan-cancer cohorts, RPS13P5 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RPS13P5’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RPS13P5 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPS13P5 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

COAD, CHOL, and THCA are the cancer types where RPS13P5 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS13P5 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	All	+0.169	.017	2	view →
CHOL	Female	All	+0.323	<.001	1	view →
THCA	Male	All	−0.081	.032	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RPS13P5–COAD

Open the COAD breakdown →